Smart Equity Invest

← Results dashboard

Q2 FY27 · NSE: TIRUPATIFL

Tirupati Forge

Results filed 5 November 2026 · Market cap ₹855 crore · PE 96.3

GrowthGuidance introducedPresentation only

Revenue
+44.5%
on a year ago
EBITDA
+127.2%
on a year ago
Profit to shareholders
+207.5%
on a year ago
EBITDA margin
12.8%
+1.4 pts on last quarter

Tirupati Forge posted robust Q2FY27 financial performance with revenue of ₹57.3 crore and PAT of ₹4.12 crore, driven by strong export demand from North America. The company secured a DPIIT defence manufacturing licence and completed pilot batches for 155mm M107 and 155mm ERFB shells, targeting commercial production by Q4 FY27 and H1 FY28 respectively. The business remains heavily reliant on the Oil & Gas sector and flange products, which both contribute approximately two-thirds of total sales.

Tirupati Forge Limited, Q2 FY27₹ crore, standalone
Q2 FY27Q1 FY27vs previous quarterQ2 FY26vs a year ago
Revenue57.3238.1+50.4%39.67+44.5%
Operating profit (EBIT)5.12.28+123.7%1.44+254.2%
Operating margin8.9%6.0%+291 bps3.6%+527 bps
Other income0.830.33+151.5%1.06−21.7%
Exceptional items00–0–
Profit before exceptional items and tax5.431.66+227.1%1.84+195.1%
Profit to shareholders4.121.22+237.7%1.34+207.5%
Earnings per share (₹)–0.20–0.11–

Source: Tirupati Forge Limited’s filing to NSE, 5 November 2026. That filing gives only the year to date, so this quarter is it less the year to date in the previous quarter’s filing. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.

These notes are from the presentation and press release. The concall transcript isn’t filed yet; the notes are rewritten when it is.

What stood out

  • Sharp QoQ and YoY acceleration in financial performance, with PAT jumping 238% QoQ and EBITDA margin expanding substantially.
    SourceTotal Income rose 51% QoQ to INR 581.5 mn, EBITDA grew 74% QoQ to INR 81.88 mn, and PAT rose 238% QoQ to INR 41.2 mn (Presentation, Original Page 4); reported EBITDA margin expanded 4.7pp YoY to 12.84%.
  • Key milestone achievements in defence vertical with DPIIT licence receipt and manufacturing validation stages reached for 155mm artillery shells.
    Source"Successfully completed the manufacturing of the first batch of 200 units of 155mm M107 empty shells... completed the forging and machining of the 155mm ERFB shell body" and "secured the requisite manufacturing licence from DPIIT" (Presentation, Original Page 3 and Page 5).

Guidance

MetricGuidancePeriod
Commercial production commencement for 155mm M107 shells
Source"Expect to commence commercial production in Q4 FY27." (Presentation, Original Page 5)
Q4 FY27Q4 FY27
Commercial production commencement for 155mm ERFB shells
Source"Commercial production is expected to commence by H1 FY28." (Presentation, Original Page 5)
H1 FY28H1 FY28

Tailwinds

  • Robust export demand from North America powering revenue and margin expansion.
    Source"We have witnessed healthy growth in our business, driven particularly by strong demand from the North American market." (Presentation, Original Page 3)
  • Receipt of statutory industrial defence licence enabling entry into defence manufacturing.
    Source"Received DPIIT Manufacturing Licence: This marks a significant step in strengthening the company's defence manufacturing capabilities" (Presentation, Original Page 5)

Headwinds

None named.

New businesses and products

new product · Completed initial batch of 200 units; final inspection completed by Defence team and awaiting proof testing results.

155mm M107 Empty Shells

Expected benefit
Establish scalable presence in defence manufacturing and entry into domestic/global artillery ammunition supply.
Risks
Dependence on successful proof testing results and defence validation.
Timeline
Commercial production expected to commence in Q4 FY27.
Source"Successfully completed the manufacturing of the first batch of 200 units of 155mm M107 empty shells... Expect to commence commercial production in Q4 FY27." (Presentation, Original Page 5)

new product · Forging and machining completed; commercial interest received from multiple global prospective customers.

155mm ERFB Shell Body

Expected benefit
Positions company among a select group of global manufacturers for highly specialised defence products and opens up international defence export opportunities.
Risks
Customer conversion, testing, and qualification hurdles in international defence markets.
Timeline
Commercial production expected to commence by H1 FY28.
Source"Successfully completed the forging and machining of the 155mm ERFB shell body... Commercial production is expected to commence by H1 FY28." (Presentation, Original Page 5)

Things to check

  • Significant revenue concentration in a single product line and end-market industry.
    SourceFlanges account for 66.67% of sales by product group, and Oil & Gas accounts for 66.66% of sales by customer industry (Presentation, Original Page 8).
  • Inconsistency in reported export revenue mix within the same presentation.
    SourceSlide 'Tirupati Forging at Glance' states '55% of the revenue is attributed to overseas market' (Presentation, Original Page 6), whereas the pie chart on slide 'Diversified Portfolio' reports Global share as 69% and Domestic as 31% (Presentation, Original Page 8).

How the call went

Not yet: there’s no transcript.

Numbers against the story

The narrative highlights strong operating leverage and demand from the North American market, which aligns with reported revenue reaching ₹57.3 crore (+44.3% YoY, +50.4% QoQ) and EBITDA margin expanding 4.7pp YoY to 12.84%. However, while the narrative places heavy emphasis on defence milestones, the defence segment has not yet contributed commercially to revenue, as production of the first batches remains pending proof testing and commercial rollout in Q4 FY27 and H1 FY28.

Sources

  • Investor presentation · filed 05-Nov-2026
  • Figures: the company’s results filing with NSE, linked under the table.

Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.